NCT00019630 2024-03-04Liposomal Doxorubicin in Treating Children With Refractory Solid TumorsNational Cancer Institute (NCI)Phase 1 Completed
NCT00020267 2024-03-04Vaccine Therapy in Treating Patients With Metastatic CancerNational Cancer Institute (NCI)Phase 1 Completed
NCT00720174 2016-05-17Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue SarcomaNational Cancer Institute (NCI)Phase 1 Completed30 enrolled